Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulbMona Khan, Laura Van Gerven, Lukas Marcelis et al.|Cell|2021Cited by 392
Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICUJan Gunst, Greet Van den Berghe, Yves Debaveye et al.|New England Journal of Medicine|2023Cited by 149
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trialLore Vanderbeke, Nico Janssen, Dennis C. J. J. Bergmans et al.|Intensive Care Medicine|2021Cited by 98
Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol)Jolien Onsea, Willem‐Jan Metsemakers, Saartje Uyttebroek et al.|Viruses|2021Cited by 50
Optimization of bacteriophage therapy for difficult-to-treat musculoskeletal infections: a bench-to-bedside perspectiveLaura Bessems, Jolien Onsea, Baixing Chen et al.|Frontiers in Cellular and Infection Microbiology|2024Cited by 4